アセプティック医薬品加工の世界市場、コンポーネント別(加工装置{乾燥装置、押出機、造粒装置、錠剤圧縮、充填/仕上げ装置、混合装置、その他}/包装装置{検査機、ラベリング機、無菌包装機})、技術別(乾燥、凍結乾燥、クローズドバイアル技術、ブローフィルシール技術、その他)、製品別(副腎皮質ホルモン、抗生物質、拮抗薬、生物製剤)。クローズドバイアル技術、ブローフィルシール技術、その他)、製品別(コルチコステロイド、抗生物質、拮抗薬、生物製剤、その他)、用途別(点眼剤、注射用再構成凍結乾燥粉末、無菌注射剤、吸入用水性エアゾール、その他)、地域別、競合予測および機会、2017年~2027年Global Aseptic Pharma Processing Market, By Component (Processing Equipment {Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others} v/s Packaging Equipment {Inspection Machines, Labeling Machines, Aseptic Packaging Machines}), By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others), By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others), By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others), By Region, Competition Forecast and Opportunities, 2017-2027 世界の無菌製薬加工市場は、予測期間中に大きな成長を遂げると予想されています。この成長は、医薬品、医薬品、治療用クリーム、その他の生物学的製品の保存期間を延長する要求の高まりに起因すると考えられます... もっと見る
サマリー世界の無菌製薬加工市場は、予測期間中に大きな成長を遂げると予想されています。この成長は、医薬品、医薬品、治療用クリーム、その他の生物学的製品の保存期間を延長する要求の高まりに起因すると考えられます。無菌製剤処理は、末端滅菌時の劣化や効き目の低下を避けるために行われます。この技術により、製品の品質を阻害する可能性のある細菌やその他の微生物病原体の除去が保証されます。発展途上国の人々の可処分所得の増加や環境に優しい包装への嗜好の高まりは、世界の無菌製薬処理市場の成長を加速させると予想されます。さらに、技術の進歩による包装業界の設備や技術の向上も、市場の成長を後押しする要因の一つです。特殊な無菌装置のための高い資本要件と、さまざまな慢性疾患、感染症、その他の疾病の事例の増加が、世界の無菌製薬加工市場の成長を推進しています。金融投資やその他のリソースで包装業界をサポートするための政府によるイニシアチブの増加や自己投与薬の使用量の増加は、世界の無菌製薬処理市場の成長を促進すると予想される要因の一部です。先進的な医薬品の研究や製品開発のための製薬業界におけるより高い投資も、世界の無菌製薬加工市場の成長を後押ししています。食品医薬品局(FDA)による厳しい措置は、高品質の医薬品包装に対する需要を生み出し、今後数年間、世界の無菌製薬処理市場の成長をサポートすると予想されます。世界の無菌製薬加工市場は、構成要素、技術、製品、用途、地域分布、競争環境に基づいて区分されています。地域別区分では、北米に拠点を置くバイオ製薬会社による研究開発への投資増加により、世界の無菌製薬加工市場で最大のシェアを占めると予想されます。また、米国の人々の健康に対する意識の高まりは、ジェネリック医薬品やOTC医薬品の需要増につながり、同地域の無菌製薬プロセス市場の成長を後押ししています。 世界の無菌製剤市場を支配している上位企業は、Abbvie Inc.、Lonza Group、Baxter International Inc.、Recipharm AB、August Bioservices、LLC、Vetter Pharma-Fertigung GmbH & Co.KG、Berkshire Sterile Manufacturing、Recro Pharma Inc、Samsung Biologics、Symbiosis Pharmaceutical Services Ltd.、Catalent Pharma Solutions Inc、Alcami Corporation、LSNE Contract Manufacturing、IRISYS、Robert Bosch GmbH、など。 本レポートで考慮した年数 歴史的年数:2017年~2020年 基本年:2021年 推定年:2022E 予測期間:2023F-2027F 本調査の目的 - 2017年から2021年までの世界の無菌製剤加工市場の市場規模における歴史的成長を分析すること。 - 2022Eから2027Fまでの世界の無菌製剤加工市場の市場規模および2027Fまでの成長率を推定・予測する。 - コンポーネント、加工装置、包装装置、技術、製品、用途、地域、競合環境に基づいて世界の無菌製薬加工市場を分類・予測する。 - 世界の無菌製剤加工市場における支配的な地域やセグメントを特定する。 - 世界の無菌製剤加工市場の促進要因と課題を特定する。 - 世界の無菌製剤加工市場における拡張、新製品発表、M&Aなどの競争的展開を検討する。 - 世界の無菌製剤加工市場で事業展開している主要企業のプロファイルを特定し、分析する。 - 世界の無菌製剤加工市場で市場参入企業が採用する主要な持続可能な戦略を特定する。 レポートの範囲 本レポートでは、世界の無菌製薬加工市場を、以下に詳述した業界動向に加えて、以下のカテゴリーに分類しています。 - アセプティック医薬品加工市場、コンポーネント別。 O処理装置 乾燥装置 押出し機 造粒装置 錠剤圧縮機 充填・仕上げ装置 混合機 その他 包装機器 検査機 ラベル貼付装置 アセプティック包装機 - アセプティック医薬品加工市場、技術別 o 乾燥 o 凍結乾燥 o クローズドバイアル技術 o ブローフィルシール技術 o その他 - 無菌製薬プロセス市場、製品別 o コルチコステロイド o 抗生物質 o 拮抗薬 o 生物学的製剤 o その他 - 無菌製薬プロセス市場、アプリケーション別 o 眼科用懸濁液 o 注射用の再構成された凍結乾燥粉末 o 無菌注射剤 o 吸入用水性エアロゾル o その他 - 無菌製薬プロセス市場、地域別。 o 北米 米国 メキシコ カナダ o ヨーロッパ フランス ドイツ イギリス イタリア スペイン o アジア太平洋地域 中国 インド 日本 韓国 オーストラリア o 中東・アフリカ 南アフリカ共和国 サウジアラビア UAE o 南米 ブラジル アルゼンチン コロンビア TechSci Researchは、この調査のために一次調査と徹底的な二次調査の両方を実施しました。まず、TechSci Research は世界中の企業のリストを入手しました。その後、TechSci Research は特定された企業に対して一次調査を実施しました。インタビューしながら、回答者には競合他社についても質問しました。この手法により、TechSci Research は、二次調査の制限により特定できなかった企業も含めることができました。TechSci Research は、世界中のすべての主要企業の企業、流通チャネル、存在を分析しました。 TechSci Researchは、様々なエンドユーザーセグメントのデータを記録し、将来的な予測を行うボトムアップアプローチを用いて、世界の無菌製薬処理市場の市場規模を算出した。TechSci Researchは、これらの値を業界の専門家や企業の代表者から入手し、適切で全体的な市場規模を得るためにこれらの製品タイプの履歴データを分析することで外部的に検証した。企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家向けプレゼンテーション、財務報告書など、さまざまな二次資料もTechSci Researchによって調査されました。 主な対象読者 - 無菌製薬プロセス企業/パートナー - サプライヤー/流通業者 - エンドユーザー - 規制当局や政策立案者などの政府機関 - 世界の無菌製剤加工市場に関連する組織、業界団体、フォーラム、アライアンス 本調査は、企業、パートナー、エンドユーザーなどの業界関係者にとって重要ないくつかの重要な質問に対する回答を提供し、投資戦略を立て、市場機会を活用する上で有用である。 競合他社の状況 企業プロフィール。世界の無菌製薬加工市場に存在する主要企業の詳細な分析。 利用可能なカスタマイズ。 TechSci Researchは与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供します。本レポートでは、以下のカスタマイズが可能です。 企業情報 - 追加的な市場プレイヤーの詳細分析とプロファイリング(最大5社)。 目次1. Product Overview2. Research Methodology 3. Impact of COVID-19 on Global Aseptic Pharma Processing Market 4. Voice of Customer 4.1. Factors Contributing to Demand for Aseptic Pharma Processing 4.2. Preference, By Component 4.3. Preference, By Processing Equipment 4.4. Preference, By Packaging Equipment 4.5. Commonly Used Technology in Aseptic Pharma Processing 4.6. Demand for Aseptic Pharma Processing, By Product 4.7. Brand Awareness 5. Executive Summary 6. Global Aseptic Pharma Processing Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Component (Processing Equipment v/s Packaging Equipment) 6.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 6.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 6.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 6.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 6.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 6.2.5. By Company (2021) 6.2.6. By Region 6.3. Market Map 7. North America Aseptic Pharma Processing Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Component (Processing Equipment v/s Packaging Equipment) 7.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 7.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 7.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 7.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 7.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 7.2.5. By Country 7.3. North America: Country Analysis 7.3.1. United States Aseptic Pharma Processing Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Component 7.3.1.2.2. By Technology 7.3.1.2.3. By Product 7.3.1.2.4. By Application 7.3.2. Mexico Aseptic Pharma Processing Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Component 7.3.2.2.2. By Technology 7.3.2.2.3. By Product 7.3.2.2.4. By Application 7.3.3. Canada Aseptic Pharma Processing Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Component 7.3.3.2.2. By Technology 7.3.3.2.3. By Product 7.3.3.2.4. By Application 8. Europe Aseptic Pharma Processing Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Component (Processing Equipment v/s Packaging Equipment) 8.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 8.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 8.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 8.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 8.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 8.2.5. By Country 8.3. Europe: Country Analysis 8.3.1. France Aseptic Pharma Processing Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Component 8.3.1.2.2. By Technology 8.3.1.2.3. By Product 8.3.1.2.4. By Application 8.3.2. Germany Aseptic Pharma Processing Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Component 8.3.2.2.2. By Technology 8.3.2.2.3. By Product 8.3.2.2.4. By Application 8.3.3. United Kingdom Aseptic Pharma Processing Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Component 8.3.3.2.2. By Technology 8.3.3.2.3. By Product 8.3.3.2.4. By Application 8.3.4. Italy Aseptic Pharma Processing Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Component 8.3.4.2.2. By Technology 8.3.4.2.3. By Product 8.3.4.2.4. By Application 8.3.5. Spain Aseptic Pharma Processing Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Component 8.3.5.2.2. By Technology 8.3.5.2.3. By Product 8.3.5.2.4. By Application 9. Asia-Pacific Aseptic Pharma Processing Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Component (Processing Equipment v/s Packaging Equipment) 9.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 9.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 9.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 9.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 9.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 9.2.5. By Country 9.3. Asia-Pacific: Country Analysis 9.3.1. China Aseptic Pharma Processing Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Component 9.3.1.2.2. By Technology 9.3.1.2.3. By Product 9.3.1.2.4. By Application 9.3.2. India Aseptic Pharma Processing Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Component 9.3.2.2.2. By Technology 9.3.2.2.3. By Product 9.3.2.2.4. By Application 9.3.3. Japan Aseptic Pharma Processing Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Component 9.3.3.2.2. By Technology 9.3.3.2.3. By Product 9.3.3.2.4. By Application 9.3.4. South Korea Aseptic Pharma Processing Market Outlook 9.3.4.1. Market Size & Forecast 9.3.4.1.1. By Value 9.3.4.2. Market Share & Forecast 9.3.4.2.1. By Component 9.3.4.2.2. By Technology 9.3.4.2.3. By Product 9.3.4.2.4. By Application 9.3.5. Australia Aseptic Pharma Processing Market Outlook 9.3.5.1. Market Size & Forecast 9.3.5.1.1. By Value 9.3.5.2. Market Share & Forecast 9.3.5.2.1. By Component 9.3.5.2.2. By Technology 9.3.5.2.3. By Product 9.3.5.2.4. By Application 10. South America Aseptic Pharma Processing Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Component (Processing Equipment v/s Packaging Equipment) 10.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 10.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 10.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 10.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 10.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 10.2.5. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Aseptic Pharma Processing Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Component 10.3.1.2.2. By Technology 10.3.1.2.3. By Product 10.3.1.2.4. By Application 10.3.2. Argentina Aseptic Pharma Processing Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Component 10.3.2.2.2. By Technology 10.3.2.2.3. By Product 10.3.2.2.4. By Application 10.3.3. Colombia Aseptic Pharma Processing Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Component 10.3.3.2.2. By Technology 10.3.3.2.3. By Product 10.3.3.2.4. By Application 11. Middle East and Africa Aseptic Pharma Processing Market Outlook 11.1. Market Size & Forecast 11.1.1. By Value 11.2. Market Share & Forecast 11.2.1. By Component (Processing Equipment v/s Packaging Equipment) 11.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 11.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 11.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 11.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 11.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 11.2.5. By Country 11.3. MEA: Country Analysis 11.3.1. South Africa Aseptic Pharma Processing Market Outlook 11.3.1.1. Market Size & Forecast 11.3.1.1.1. By Value 11.3.1.2. Market Share & Forecast 11.3.1.2.1. By Component 11.3.1.2.2. By Technology 11.3.1.2.3. By Product 11.3.1.2.4. By Application 11.3.2. Saudi Arabia Aseptic Pharma Processing Market Outlook 11.3.2.1. Market Size & Forecast 11.3.2.1.1. By Value 11.3.2.2. Market Share & Forecast 11.3.2.2.1. By Component 11.3.2.2.2. By Technology 11.3.2.2.3. By Product 11.3.2.2.4. By Application 11.3.3. UAE Aseptic Pharma Processing Market Outlook 11.3.3.1. Market Size & Forecast 11.3.3.1.1. By Value 11.3.3.2. Market Share & Forecast 11.3.3.2.1. By Component 11.3.3.2.2. By Technology 11.3.3.2.3. By Product 11.3.3.2.4. By Application 12. Market Dynamics 12.1. Drivers 12.2. Challenges 13. Market Trends & Developments 14. Patent Analysis 15. Competitive Landscape 15.1. Business Overview 15.2. Company Snapshot 15.3. Products & Services 15.4. Financials (In case of listed companies) 15.5. Recent Developments 15.6. SWOT Analysis 15.6.1. Abbvie Inc. 15.6.2. Lonza Group 15.6.3. Baxter International Inc. 15.6.4. Recipharm AB 15.6.5. August Bioservices, LLC 15.6.6. Vetter Pharma-Fertigung GmbH & Co. KG 15.6.7. Berkshire Sterile Manufacturing 15.6.8. Recro Pharma Inc. 15.6.9. Samsung Biologics 15.6.10. Symbiosis Pharmaceutical Services Ltd. 15.6.11. Catalent Pharma Solutions Inc. 15.6.12. Alcami Corporation 15.6.13. LSNE Contract Manufacturing 15.6.14. IRISYS 15.6.15. Robert Bosch GmbH 16. Strategic Recommendations
SummaryThe global aseptic pharma processing market is expected to grow at a significant rate during the forecast period. The growth can be attributed to the rising demands for prolonged shelf-life of drugs, medicines, therapeutic creams, and other biological products. Aseptic pharma processing is performed to avoid degradation and ineffectiveness during terminal sterilizing. The technique guarantees the removal of bacteria and other microbial pathogens that can hamper the quality of the product. Increasing disposable income of people in developing countries and rising preference for eco-friendly packaging are anticipated to accelerate the growth of the global aseptic pharma processing market. Moreover, improved equipment and technologies in the packaging industry due to advances in technology are some of the factors driving the growth of the market. High capital requirement for specialized aseptic equipment and increasing instances of various chronic diseases, infectious diseases, and other illnesses are propelling the global aseptic pharma processing market growth. Increasing initiatives by the government to support the packaging industry with financial investments and other resources and growing usage of self-administered drugs are some of the factors expected to boost the growth of the global aseptic pharma processing market. Higher investment in the pharmaceutical industry for research and product development for the advanced pharmaceuticals are also propelling the growth of the global aseptic pharma processing market. Stringent measures by the Food & Drug Administration (FDA) have created a demand for high-quality pharma product packaging, which is expected to support the growth of global aseptic pharma processing market in the coming years. Table of Contents1. Product Overview2. Research Methodology 3. Impact of COVID-19 on Global Aseptic Pharma Processing Market 4. Voice of Customer 4.1. Factors Contributing to Demand for Aseptic Pharma Processing 4.2. Preference, By Component 4.3. Preference, By Processing Equipment 4.4. Preference, By Packaging Equipment 4.5. Commonly Used Technology in Aseptic Pharma Processing 4.6. Demand for Aseptic Pharma Processing, By Product 4.7. Brand Awareness 5. Executive Summary 6. Global Aseptic Pharma Processing Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Component (Processing Equipment v/s Packaging Equipment) 6.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 6.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 6.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 6.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 6.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 6.2.5. By Company (2021) 6.2.6. By Region 6.3. Market Map 7. North America Aseptic Pharma Processing Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Component (Processing Equipment v/s Packaging Equipment) 7.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 7.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 7.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 7.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 7.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 7.2.5. By Country 7.3. North America: Country Analysis 7.3.1. United States Aseptic Pharma Processing Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Component 7.3.1.2.2. By Technology 7.3.1.2.3. By Product 7.3.1.2.4. By Application 7.3.2. Mexico Aseptic Pharma Processing Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Component 7.3.2.2.2. By Technology 7.3.2.2.3. By Product 7.3.2.2.4. By Application 7.3.3. Canada Aseptic Pharma Processing Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Component 7.3.3.2.2. By Technology 7.3.3.2.3. By Product 7.3.3.2.4. By Application 8. Europe Aseptic Pharma Processing Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Component (Processing Equipment v/s Packaging Equipment) 8.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 8.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 8.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 8.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 8.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 8.2.5. By Country 8.3. Europe: Country Analysis 8.3.1. France Aseptic Pharma Processing Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Component 8.3.1.2.2. By Technology 8.3.1.2.3. By Product 8.3.1.2.4. By Application 8.3.2. Germany Aseptic Pharma Processing Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Component 8.3.2.2.2. By Technology 8.3.2.2.3. By Product 8.3.2.2.4. By Application 8.3.3. United Kingdom Aseptic Pharma Processing Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Component 8.3.3.2.2. By Technology 8.3.3.2.3. By Product 8.3.3.2.4. By Application 8.3.4. Italy Aseptic Pharma Processing Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Component 8.3.4.2.2. By Technology 8.3.4.2.3. By Product 8.3.4.2.4. By Application 8.3.5. Spain Aseptic Pharma Processing Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Component 8.3.5.2.2. By Technology 8.3.5.2.3. By Product 8.3.5.2.4. By Application 9. Asia-Pacific Aseptic Pharma Processing Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Component (Processing Equipment v/s Packaging Equipment) 9.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 9.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 9.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 9.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 9.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 9.2.5. By Country 9.3. Asia-Pacific: Country Analysis 9.3.1. China Aseptic Pharma Processing Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Component 9.3.1.2.2. By Technology 9.3.1.2.3. By Product 9.3.1.2.4. By Application 9.3.2. India Aseptic Pharma Processing Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Component 9.3.2.2.2. By Technology 9.3.2.2.3. By Product 9.3.2.2.4. By Application 9.3.3. Japan Aseptic Pharma Processing Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Component 9.3.3.2.2. By Technology 9.3.3.2.3. By Product 9.3.3.2.4. By Application 9.3.4. South Korea Aseptic Pharma Processing Market Outlook 9.3.4.1. Market Size & Forecast 9.3.4.1.1. By Value 9.3.4.2. Market Share & Forecast 9.3.4.2.1. By Component 9.3.4.2.2. By Technology 9.3.4.2.3. By Product 9.3.4.2.4. By Application 9.3.5. Australia Aseptic Pharma Processing Market Outlook 9.3.5.1. Market Size & Forecast 9.3.5.1.1. By Value 9.3.5.2. Market Share & Forecast 9.3.5.2.1. By Component 9.3.5.2.2. By Technology 9.3.5.2.3. By Product 9.3.5.2.4. By Application 10. South America Aseptic Pharma Processing Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Component (Processing Equipment v/s Packaging Equipment) 10.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 10.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 10.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 10.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 10.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 10.2.5. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Aseptic Pharma Processing Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Component 10.3.1.2.2. By Technology 10.3.1.2.3. By Product 10.3.1.2.4. By Application 10.3.2. Argentina Aseptic Pharma Processing Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Component 10.3.2.2.2. By Technology 10.3.2.2.3. By Product 10.3.2.2.4. By Application 10.3.3. Colombia Aseptic Pharma Processing Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Component 10.3.3.2.2. By Technology 10.3.3.2.3. By Product 10.3.3.2.4. By Application 11. Middle East and Africa Aseptic Pharma Processing Market Outlook 11.1. Market Size & Forecast 11.1.1. By Value 11.2. Market Share & Forecast 11.2.1. By Component (Processing Equipment v/s Packaging Equipment) 11.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others) 11.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines) 11.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others) 11.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others) 11.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others) 11.2.5. By Country 11.3. MEA: Country Analysis 11.3.1. South Africa Aseptic Pharma Processing Market Outlook 11.3.1.1. Market Size & Forecast 11.3.1.1.1. By Value 11.3.1.2. Market Share & Forecast 11.3.1.2.1. By Component 11.3.1.2.2. By Technology 11.3.1.2.3. By Product 11.3.1.2.4. By Application 11.3.2. Saudi Arabia Aseptic Pharma Processing Market Outlook 11.3.2.1. Market Size & Forecast 11.3.2.1.1. By Value 11.3.2.2. Market Share & Forecast 11.3.2.2.1. By Component 11.3.2.2.2. By Technology 11.3.2.2.3. By Product 11.3.2.2.4. By Application 11.3.3. UAE Aseptic Pharma Processing Market Outlook 11.3.3.1. Market Size & Forecast 11.3.3.1.1. By Value 11.3.3.2. Market Share & Forecast 11.3.3.2.1. By Component 11.3.3.2.2. By Technology 11.3.3.2.3. By Product 11.3.3.2.4. By Application 12. Market Dynamics 12.1. Drivers 12.2. Challenges 13. Market Trends & Developments 14. Patent Analysis 15. Competitive Landscape 15.1. Business Overview 15.2. Company Snapshot 15.3. Products & Services 15.4. Financials (In case of listed companies) 15.5. Recent Developments 15.6. SWOT Analysis 15.6.1. Abbvie Inc. 15.6.2. Lonza Group 15.6.3. Baxter International Inc. 15.6.4. Recipharm AB 15.6.5. August Bioservices, LLC 15.6.6. Vetter Pharma-Fertigung GmbH & Co. KG 15.6.7. Berkshire Sterile Manufacturing 15.6.8. Recro Pharma Inc. 15.6.9. Samsung Biologics 15.6.10. Symbiosis Pharmaceutical Services Ltd. 15.6.11. Catalent Pharma Solutions Inc. 15.6.12. Alcami Corporation 15.6.13. LSNE Contract Manufacturing 15.6.14. IRISYS 15.6.15. Robert Bosch GmbH 16. Strategic Recommendations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(アレルギー用薬)の最新刊レポート
TechSci Research社のアレルギー用薬分野での最新刊レポート
本レポートと同じKEY WORD(antibiotics)の最新刊レポート
よくあるご質問TechSci Research社はどのような調査会社ですか?テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |